Van ECK Associates Corp Boosts Stock Position in Exponent, Inc. (NASDAQ:EXPO)

Van ECK Associates Corp boosted its position in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 40.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,194 shares of the business services provider’s stock after acquiring an additional 10,342 shares during the quarter. Van ECK Associates Corp’s holdings in Exponent were worth $3,876,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Quarry LP purchased a new position in shares of Exponent in the 2nd quarter valued at about $25,000. GAMMA Investing LLC increased its stake in Exponent by 67.7% in the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock worth $49,000 after purchasing an additional 323 shares in the last quarter. USA Financial Formulas purchased a new stake in shares of Exponent during the 3rd quarter worth approximately $60,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Exponent by 70.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after buying an additional 361 shares in the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Up 0.7 %

Shares of NASDAQ EXPO opened at $104.97 on Friday. The business has a 50-day moving average price of $107.64 and a 200 day moving average price of $101.57. The stock has a market cap of $5.33 billion, a PE ratio of 50.71 and a beta of 0.69. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s payout ratio is currently 54.11%.

Insider Activity

In other news, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now directly owns 80,742 shares of the company’s stock, valued at $8,445,613.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the transaction, the director now owns 80,742 shares in the company, valued at $8,445,613.20. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

Separately, Truist Financial reissued a “buy” rating and issued a $120.00 price target (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Read Our Latest Report on EXPO

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.